Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Gilead Sciences, Second Genome form IBD drug discovery alliance Gilead Sciences has entered into a four-year deal worth up to $338 million with California-based clinical-stage company Second… bypharmanewsdailyApril 9, 2020
